Healthcare - Biotechnology - NASDAQ - US
$ 2.36
-19.7 %
$ 81.5 M
Market Cap
-2.38
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
428.54%
EBIT
Estimate
40.78%
Net Income
Estimate
27.56%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Genelux Corporation
GNLX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart GNLX
EBIT FORECAST
EBIT Forecast Chart GNLX
NET INCOME FORECAST
Net Income Chart GNLX